The rationale for combining a GHRH analog with ipamorelin is synergy: the two act through different receptors (GHRH receptor and ghrelin receptor) and different intracellular pathways, producing a GH pulse larger than either compound alone in animal models
Starting with high doses (1,000 mcg to 2,000 mcg) weekly or biweekly is common
For drug treatment, DFP (75 mg/kg, intraperitoneally, synthesized in China Peptides Co., Ltd., Shanghai, China) or DMT1i (50 mg/kg, orally, MedChemExpress, China) [19, 20] was administered to the animals 1 h before GA daily for three consecutive days
Using a mouse model of polygenic T2D, we demonstrate that chronic glibenclamide therapy does more than simply reduce insulin secretion